EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
42 hedge funds and large institutions have $23M invested in EnteroMedics Inc. in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 9 closing their positions.
12% more capital invested
Capital invested by funds: $20.6M → $23M (+$2.37M)
2% less funds holding
Funds holding: 43 → 42 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$340K |
| 2 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$221K |
| 3 |
Millennium Management
New York
|
+$221K |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$183K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$183K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$389K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$313K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$177K |
| 4 |
Barclays
London,
United Kingdom
|
-$106K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$94.3K |
ETRM Hedge Fund Activity: Q3 2013 in Review
42 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q3 2013, worth a combined $23M — up 12% from $20.6M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ETRM and 8 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 9 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $340K. The largest seller was Wells Fargo, cutting an estimated $389K.
- 42 institutional investors held EnteroMedics Inc. (ETRM) as of Q3 2013, down from 43 in Q2 2013.
- Funds reported $23M of EnteroMedics Inc. stock for Q3 2013, up 12% quarter-over-quarter.
- 8 funds opened new EnteroMedics Inc. positions in Q3 2013 and 9 closed out, a net change of -1 holder.
- The largest EnteroMedics Inc. buyer in Q3 2013 was Renaissance Technologies, an estimated $340K added.
- The largest EnteroMedics Inc. seller in Q3 2013 was Wells Fargo, an estimated $389K sold.
Based on aggregated 13F filings for Q3 2013.